OESOPHAGEAL DYSPLASIA

OESOPHAGEAL DYSPLASIA was reported 52 times

These drug classes are most commonly taken by patients reporting OESOPHAGEAL DYSPLASIA:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 6
1 Platelet Aggregation Inhibitor [EPC] 5
2 Benzodiazepine [EPC] 4
3 Corticosteroid [EPC] 4
4 HMG-CoA Reductase Inhibitor [EPC] 4
5 Proton Pump Inhibitor [EPC] 4
6 Interleukin-5 Antagonist [EPC] 3
7 P2Y12 Platelet Inhibitor [EPC] 3
8 Tumor Necrosis Factor Blocker [EPC] 3
9 Histamine-2 Receptor Antagonist [EPC] 2
10 Janus Kinase Inhibitor [EPC] 2
11 Nitrate Vasodilator [EPC] 2
12 Phosphodiesterase 4 Inhibitor [EPC] 2
13 Prostacycline Vasodilator [EPC] 2
14 Soluble Guanylate Cyclase Stimulator [EPC] 2
15 5-alpha Reductase Inhibitor [EPC] 1
16 Aluminum Complex [EPC] 1
17 Angiotensin 2 Receptor Blocker [EPC] 1
18 Angiotensin Converting Enzyme Inhibitor [EPC] 1
19 Dietary Cholesterol Absorption Inhibitor [EPC] 1
20 Expectorant [EPC] 1
21 Factor Xa Inhibitor [EPC] 1
22 GLP-1 Receptor Agonist [EPC] 1
23 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
24 Guanylate Cyclase-C Agonist [EPC] 1
25 Interferon alfa-2b [EPC] 1
26 Interleukin-6 Receptor Antagonist [EPC] 1
27 Loop Diuretic [EPC] 1
28 Parathyroid Hormone-Related Peptide Analog [EPC] 1
29 Phosphodiesterase 5 Inhibitor [EPC] 1
30 Platinum-based Drug [EPC] 1
31 Prostaglandin Analog [EPC] 1
32 Provitamin D2 Compound [EPC] 1
33 Retinoid [EPC] 1
34 Sigma-1 Agonist [EPC] 1
35 Sulfonylurea [EPC] 1
36 Thalidomide Analog [EPC] 1
37 Topoisomerase Inhibitor [EPC] 1
38 Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] 1
39 Vitamin B12 [EPC] 1
40 Vitamin C [EPC] 1
41 beta-Adrenergic Blocker [EPC] 1
42 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1